The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med1997; 336: 525–533.
2.
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med1991; 325: 293–302.
3.
GargRYusufS. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA1995; 273: 1450–1456.
4.
WaagsteinFBristowMRSwedbergKCameriniFFowlerMBBeneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet1993; 342: 1441–1446.
5.
CIBIS Investigators and committees. A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation1994; 90: 1765–1773.
6.
PackerMBristowMRCohnJNColucciWSFowlerMBThe effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med1996; 334: 1349–1355.
7.
Australian/New Zealand Heart Failure Research Collaborative Group. Randomized placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet1997; 349: 375–383.
8.
SwedburgKHjalmarsonÅWaagsteinFWallentinI. Prolongation of survival in congestive cardiomyopathy during treatment with beta-receptor blockade. Lancet1979; 1: 1374–1376.
9.
BristowMRGilbertEMAbrahamWTAdamsKFFowlerMB. Carvedilol produces dose related-improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation1996; 94: 2807–2816.
10.
ColucciWSPackerMBristowMRGilbertMCohnJ. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation1996; 94: 2800–2806.
11.
PackerMColucciWSSackner-BernsteinJDLiangCSGoldscherDADouble-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure – The Precise Trial. Circulation1996; 94: 2793–2799.
12.
CohnJFowlerMBBristowMRSafety and efficacy of carvedilol in severe heart failure. J Cardiac Failure1997; 3: 173–179.
13.
LechatPPackerMChalonSCucheratMArabTBoisselJP. Clinical effects of β-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind placebo-controlled, randomised trials. Circulation1998; 98: 1184–1191.
14.
DoughtyRNRodgersASharpeNMacMahonS. Effects of beta-blocker therapy on mortality in patients with heart failure: a systematic overview of randomized controlled trials. Eur Heart J1997; 18: 560–565.
15.
HeidenreichPALeeTTMassieBM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol1997; 30: 27–34.
16.
BriatowMRO'ConnellJBGilbertEMFrenchWJLeathermanGDose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Circulation1994; 89: 1632–1642.
17.
PackerM. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure. Am J Cardiol1997; 80: 46L–54L.
